Usefulness of monitoring mycophenolic acid exposure in systemic sclerosis-related interstitial lung disease: a retrospective cohort study
Our study suggests that optimal MPA exposure, as indicated by RR levels, may better protect against FVC decline in SSc-ILD patients treated with MMF. Routine monitoring of MPA exposure could be beneficial in optimizing treatment outcomes. Prospective, multicenter studies are needed to further explore the relationship between MPA exposure and clinical outcomes in SSc-ILD.
Authors
- Benjamin Coiffard (ORCID: https://orcid.org/0000-0002-8896-5346)
- Martine Reynaud‐Gaubert (ORCID: https://orcid.org/0000-0002-5236-5867)
- Julien Bermudez (ORCID: https://orcid.org/0000-0001-8823-0959)
- Emmanuelle Sampol
- Ana Nieves (ORCID: https://orcid.org/0000-0003-4825-9161)
- A. Benyamine (ORCID: https://orcid.org/0000-0003-4187-3425)
- B. Granel (ORCID: https://orcid.org/0000-0001-7995-8817)
- Jules Milesi (ORCID: https://orcid.org/0009-0003-6230-1570)
- Shani Diai
Institutions
- Inserm (FR)
- Aix-Marseille Université (FR)
- Assistance Publique Hôpitaux de Marseille (FR)
- Unité de recherche sur les maladies cardiovasculaires et métaboliques (FR)
- Nutrition, Obésité et Risque Thrombotique (FR)
Publication Details
- Journal
- BMC Pulmonary Medicine
- Published
- 2024-10-28
- DOI
- https://doi.org/10.1186/s12890-024-03361-7
- Citations
- 2
- Primary Topic
- Systemic Sclerosis and Related Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.85